中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Structural optimization and biological evaluation of l,5-disubstituted pyrazole-3-carboxamines as potent inhibitors of human 5-lipoxygenase

文献类型:期刊论文

作者Zhou Yu3; Liu Jun2; Zheng Mingyue3; Zheng Shuli1; Jiang Chunyi3; Zhou Xiaomei1; Zhang Dong3; Zhao Jihui3; Ye Deju3; Zheng Mingfang3
刊名Acta Pharmaceutica Sinica B
出版日期2016
卷号6期号:1页码:32
关键词5-Lipoxygenase 5-LOX inhibitors Pyrazole derivatives Leukotrienes-related diseases In vivo Benzo-fused heterocycle Ischemic incults Brain inflammation
ISSN号2211-3835
英文摘要Human 5-lipoxygenase (5-LOX) is a well-validated drug target and its inhibitors are potential drugs for treating leukotriene-related disorders. Our previous work on structural optimization of the hit compound 2 from our in-house collection identified two lead compounds, 3a and 3b, exhibiting a potent inhibitory profile against 5-LOX with IC_(50) values less than 1 μmol/L in cell-based assays. Here,we further optimized these compounds to prepare a class of novel pyrazole derivatives by opening the fused-ring system. Several new compounds exhibited more potent inhibitory activity than the lead compounds against 5-LOX. In particular, compound 4e not only suppressed lipopolysaccharide-induced inflammation in brain inflammatory cells and protected neurons from oxidative toxicity, but also significantly decreased infarct damage in a mouse model of cerebral ischemia. Molecular docking analysis further confirmed the consistency of our theoretical results and experimental data. In conclusion, the excellent in vitro and in vivo inhibitory activities of these compounds against 5-LOX suggested that these novel chemical structures have a promising therapeutic potential to treat leukotriene-related disorders.
语种英语
源URL[http://119.78.100.183/handle/2S10ELR8/294487]  
专题中国科学院上海药物研究所
作者单位1.中国科学院上海生命科学研究院神经科学研究所
2.中国药科大学
3.中国科学院上海药物研究所
推荐引用方式
GB/T 7714
Zhou Yu,Liu Jun,Zheng Mingyue,et al. Structural optimization and biological evaluation of l,5-disubstituted pyrazole-3-carboxamines as potent inhibitors of human 5-lipoxygenase[J]. Acta Pharmaceutica Sinica B,2016,6(1):32.
APA Zhou Yu.,Liu Jun.,Zheng Mingyue.,Zheng Shuli.,Jiang Chunyi.,...&Liu Hong.(2016).Structural optimization and biological evaluation of l,5-disubstituted pyrazole-3-carboxamines as potent inhibitors of human 5-lipoxygenase.Acta Pharmaceutica Sinica B,6(1),32.
MLA Zhou Yu,et al."Structural optimization and biological evaluation of l,5-disubstituted pyrazole-3-carboxamines as potent inhibitors of human 5-lipoxygenase".Acta Pharmaceutica Sinica B 6.1(2016):32.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。